Evidence mapPaperPMID 41909684Full record

ArticleFrontiers in immunology2026

Immune reconstitution efficacy and associated risk factors for immunological non-response in people living with HIV during long-term antiretroviral therapy: a single-center retrospective cohort study at a tertiary care hospital in China.

Rui Li, Lifeng Liu, Ran Wang, Yuanyi Zhai, Yiming Ren, Wei Hua, Yang Zhang, Lijun Sun, Lili Dai

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rui Li *Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Lifeng Liu *Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for HIV/AIDS Research, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Ran WangCenter for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Yuanyi ZhaiCenter for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Yiming RenCenter for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Wei HuaCenter for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Yang ZhangCenter for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Lijun SunCenter for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Lili DaiCenter for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite sustained virological suppression under antiretroviral therapy (ART), a substantial proportion of people living with HIV (PLWH) fail to achieve adequate immune reconstitution. However, long-term real-world evidence characterizing immune recovery trajectories and determinants of immunological non-response (INR) has not yet been fully characterized, particularly in Asian populations. In this retrospective cohort study, we analyzed longitudinal immunological data from 8,637 PLWH who initiated ART between 2005 and 2019 at a large HIV treatment center in China and achieved sustained viral suppression. CD4 counts, CD8 counts, and CD4/CD8 ratios were assessed longitudinally to characterize immune reconstitution patterns, and Kaplan-Meier analyses and logistic regression models were used to evaluate factors associated with immune recovery and INR. We observed a biphasic pattern of immune reconstitution, with rapid early increases in CD4 counts and CD4/CD8 ratios followed by slower, sustained improvements over long-term ART. Nevertheless, normalization of the CD4/CD8 ratio occurred less frequently than CD4 count recovery, indicating persistent immune dysregulation in a subset of patients despite virological control. Lower baseline CD4 count and older age were the strongest predictors of incomplete immune reconstitution, with individuals initiating ART at advanced stages of immunodeficiency showing markedly reduced probability and slower tempo of immune normalization. These findings highlight the heterogeneity of immune recovery under long-term ART and underscore the importance of incorporating baseline immune status and age into risk stratification strategies. Longitudinal assessment of both CD4 counts and CD4/CD8 ratios may provide complementary insights into immune restoration and inform individualized monitoring and management of PLWH receiving ART.

Indexed as

Anti-HIV AgentsHIV-1HIV InfectionsImmune ReconstitutionAdultAntiretroviral Therapy, Highly ActiveCD4-CD8 RatioCD4 Lymphocyte CountChinaFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsTertiary Care CentersAnti-HIV Agentsantiretroviral therapyCD4/CD8 ratiocohort studyHIVimmune reconstitutionimmunological non-response

Identifiers

PMID41909684
PMCPMC13021817

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.